Last year, as reauthorizing legislation for the Food and Drug Administration was nearing ratification, the Obama administration urged the agency to speed its approval process for new drug candidates. It appears uncertain whether the administration was buying the pharma line that stringent regulatory review costs jobs or if the White House staff counseled bending over backwards for hostile Republicans by favoring a policy of lax regulation.
Despite the administration's election season posturing, Democrats have traditionally encouraged a rigorous FDA. Democratic congressmen such as Henry Waxman and John Dingell in the House, together with their party colleagues elsewhere in Washington, generally held the FDA's feet to the fire by demanding careful reviews. But Republicans have also come down on both sides of favoring tough versus lenient drug regulation. Charles Grassley, Republican senator from Iowa, remains one of the staunchest legislators in terms of demanding that the FDA not act as the drug industry's pet.
The example of Grassley notwithstanding, conservatives generally favor public policies that emphasize "values." Typically, this means a combination of repressive Victorian morality and a despotic Christian theology. But the term they prefer to use in connection with their animating regulatory principle is "freedom," defined as a lack of government restrictions. In practice, they pursue freedom as it permits wealthy individuals and corporations to exploit advantages in the market.
Sabeel Rahman of Harvard makes the point that over the past 100 years, progressive reformers in the U.S. have also opposed dangers to freedom that come from sources beside arbitrary state power. Powerful private entities such as corporations pose an even more intrusive threat to individual freedom. In this progressive vision, "government is not an obstacle to freedom that must be dismantled; rather it is a vital tool that can help expand individual freedom."